0 Comentários
0 Compartilhamentos
83 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Boron Neutron Capture Therapy System Market – Targeted Radiation Approach Advancing Oncology TreatmentMarket Overview The boron neutron capture therapy system market is gaining attention as a targeted radiotherapy approach capable of selectively destroying cancer cells while sparing surrounding healthy tissue. This technique relies on boron-containing compounds accumulating preferentially in tumor cells, which are then activated by neutron irradiation to release cell-destroying particles with...0 Comentários 0 Compartilhamentos 36 Visualizações 0 Anterior
-
Cyclin Dependent Kinase Inhibitor Market – Precision Oncology Advancing Through Targeted Cell Cycle TherapyMarket Overview The cyclin dependent kinase inhibitor market is expanding rapidly as oncology shifts toward precision therapies that halt uncontrolled cell division at its source. These inhibitors block specific enzymes responsible for driving the cell cycle in cancer cells, particularly in breast cancer and other hormone-receptor-positive malignancies. Growth is fueled by rising cancer...0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior
-
Global Histiocytic Lymphoma Treatment Market Report: Targeted Therapy, Immunotherapy and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Histiocytic Lymphoma Treatment Market CAGR Value The global histiocytic lymphoma treatment market size was valued at USD 650.00 million in 2025 and is expected to reach USD 1,005.13 million by 2033, at a CAGR of 5.60% during the forecast period In this persuasive...0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior
-
HER2 Therapy Market Demand: Expanding Use of Targeted Therapies in HER2-Positive CancerThe HER2 therapy market is projected to grow from USD 16.8 billion in 2026 to USD 38.7 billion by 2036, registering a CAGR of 8.7%, according to Future Market Insights. The market is gaining momentum as advances in biomarker testing expand treatment eligibility and pharmaceutical companies develop targeted therapies for HER2-positive, HER2-low, and HER2-ultralow cancers. The market is expected...0 Comentários 0 Compartilhamentos 24 Visualizações 0 Anterior
-
Janus Kinase (JAK) Inhibitors Market – Targeted Therapy Transforming Autoimmune Disease ManagementMarket Overview The Janus kinase (JAK) inhibitors market continues to expand as targeted oral therapies increasingly replace or complement biologic injectables across rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and atopic dermatitis management. JAK inhibitors offer patients the convenience of oral dosing alongside rapid onset of action, reshaping treatment algorithms...0 Comentários 0 Compartilhamentos 99 Visualizações 0 Anterior
-
Small Molecule Targeted Cancer Therapy Market – Industry Trends and Forecast to 2030Small Molecule Targeted Cancer Therapy Market According to the latest report published by Data Bridge Market Research, the Small Molecule Targeted Cancer Therapy Market Data Bridge Market Research analyses that the global small molecule targeted cancer therapy market which was USD 75,960.00 Million in 2022, would rocket up to USD 124,772.24 Million by 2030 and is expected...0 Comentários 0 Compartilhamentos 150 Visualizações 0 Anterior
-
Targeted Radionuclide Therapy Market Evolution Through Breakthrough Therapeutic InnovationsLooking toward 2034, the Targeted Radionuclide Therapy Market is expected to be a cornerstone of modern oncology. As our ability to target cancers at the molecular level improves, these therapies will likely become a primary treatment option rather than a last resort. Continuous improvements in isotope availability, such as the adoption of cyclotron-based production, will alleviate previous...0 Comentários 0 Compartilhamentos 246 Visualizações 0 Anterior
-
The Evolution of Autoimmune Hemolytic Anemia Treatment: From Immunosuppressive Therapy to Targeted BiologicsAutoimmune hemolytic anemia (AIHA) is a rare and complex red blood cell disorder where the immune system mistakenly produces antibodies that attack and destroy the body's own red blood cells. This leads to varying degrees of anemia, ranging from mild fatigue to life-threatening hemolytic crises. The management of this condition requires careful diagnosis and a tailored therapeutic approach. The...0 Comentários 0 Compartilhamentos 207 Visualizações 0 Anterior
-
The Targeted Attack: How Peptide Receptor Radionuclide Therapy is Revolutionizing Neuroendocrine Tumor TreatmentNeuroendocrine tumors (NETs) are a diverse group of malignancies that arise from neuroendocrine cells, often presenting with slow growth but posing significant challenges due to their ability to metastasize and cause debilitating hormonal symptoms. For decades, treatment options for advanced NETs were limited. Peptide receptor radionuclide therapy (PRRT) has emerged as a game-changing...0 Comentários 0 Compartilhamentos 225 Visualizações 0 Anterior
-
Why Chemotherapy and Targeted Therapy Are Leading Treatment Types in AML TreatmentThe global acute myeloid leukemia treatment market is growing as healthcare providers invest in advanced therapeutic solutions to improve patient outcomes. The market was valued at USD 3.201 billion in 2024 and is projected to reach USD 7.027 billion by 2035, growing at a CAGR of 7.41%. The Acute Myeloid Leukemia Treatment Market includes chemotherapy, targeted therapy, immunotherapy, stem cell...0 Comentários 0 Compartilhamentos 44 Visualizações 0 Anterior
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Comentários 0 Compartilhamentos 744 Visualizações 0 Anterior
-
Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Rare Neurological Disease Treatment Market Competitive Landscape and Key PlayersThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Comentários 0 Compartilhamentos 956 Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek